LRRK2 and Parkinson disease: Moreover, several reports have attempted to utilize phosphorylated Rab10 as a biomarker for upregulated LRRK2 activities in PD or preclinical models, which was shown to be successful to a certain extent, although results vary between studies [100,101,102,103,104,105,106,107,108,109].